103 related articles for article (PubMed ID: 7504383)
1. Chronic active anti-HCV positive hepatitis and post-hepatitis C cirrhosis: role of interferon.
Perasso A; Testino G; Cheli R
Acta Gastroenterol Latinoam; 1993; 23(2):97-110. PubMed ID: 7504383
[No Abstract] [Full Text] [Related]
2. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
3. [Incidence of anti-HCV positivity in a Sicilian population with liver diseases].
Montalto G; Soresi M; Tripi S; Carroccio A; Bascone F; Di Martino D; Bonfissuto G; Notarbartolo A
Ann Ital Med Int; 1995; 10(2):89-92. PubMed ID: 7619657
[TBL] [Abstract][Full Text] [Related]
4. Long-term therapy with interferon in anti-HCV positive chronic hepatitis: is it conceivable?
Perasso A; Testino G; Sumberaz A; Ansaldi F
Minerva Med; 1996 Mar; 87(3):69-74. PubMed ID: 8668290
[TBL] [Abstract][Full Text] [Related]
5. Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: a 20-year multicenter study.
Wiese M; Berr F; Lafrenz M; Porst H; Oesen U
Hepatology; 2000 Jul; 32(1):91-6. PubMed ID: 10869294
[TBL] [Abstract][Full Text] [Related]
6. Cold activation of complement for monitoring the response to interferon in patients with chronic hepatitis C.
Akahane Y; Miyazaki Y; Naitoh S; Takeda K; Tsuda F; Okamoto H; Itoh K; Miyakawa Y; Mayumi M
Am J Gastroenterol; 1996 Feb; 91(2):319-27. PubMed ID: 8607500
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence of HBV surface antigens, anti-HBD and anti-HCV antibodies in patients with virus-related chronic liver disease].
Ozyilkan E; Tatar G; Köseoğlu T; Ozkuyumcu C; Kayhan B; Telatar H
Mikrobiyol Bul; 1993 Oct; 27(4):308-13. PubMed ID: 7505386
[TBL] [Abstract][Full Text] [Related]
8. Parameters predicting response to alpha-interferon treatment in chronic hepatitis C.
Glück T; Seelig R; Dette S; Bühring HJ; Renz M; Kwon S; Wiedmann KH; Weber P
Hepatogastroenterology; 1997; 44(14):484-91. PubMed ID: 9164523
[TBL] [Abstract][Full Text] [Related]
9. [Optimal antiviral therapy of chronic hepatitis caused by hepatitis C virus].
Cooreman MP; Stadhouders P
Orv Hetil; 1997 Jun; 138(22 Suppl 1):1476-82. PubMed ID: 9221377
[TBL] [Abstract][Full Text] [Related]
10. [Role of hepatitis C virus in mixed cryoglobulinemia in patients with chronic hepatitis].
Adinolfi LE; Utili R; Attanasio V; Zampino R; Pizzella T; Nardiello S; Ruggiero G
Ann Ital Med Int; 1995; 10(2):85-8. PubMed ID: 7619656
[TBL] [Abstract][Full Text] [Related]
11. Lichen planus and hepatitis C virus--related chronic active hepatitis.
Jubert C; Pawlotsky JM; Pouget F; Andre C; DeForges L; Bretagne S; Mavier JP; Duval J; Revuz J; Dhumeaux D
Arch Dermatol; 1994 Jan; 130(1):73-6. PubMed ID: 8285744
[TBL] [Abstract][Full Text] [Related]
12. [Role of hepatitis C virus in the genesis of hepatic lesions observed in alcoholic patients with liver cirrhosis].
Deny P; Halimi C; Trinchet JC; Munz C; Bianchi A; Mal F; Beaugrand M
Gastroenterol Clin Biol; 1994; 18(2):110-4. PubMed ID: 7516902
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
Scand J Infect Dis; 1995; 27(5):319-24. PubMed ID: 8588128
[TBL] [Abstract][Full Text] [Related]
14. [Compared efficiency of three strategies of management of chronic hepatitis C. Effect on the risk of cirrhosis 8 years after diagnosis].
Michel P; Merle V; Gourier C; Hochain P; Colin R; Czernichow P
Gastroenterol Clin Biol; 1996 Feb; 20(1):47-54. PubMed ID: 8734312
[TBL] [Abstract][Full Text] [Related]
15. Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: comparison in patients with hepatitis B virus- and hepatitis C virus-associated cirrhosis.
Sato A; Kato Y; Nakata K; Nakao K; Daikoku M; Ishii N; Matsumoto T; Iseki K; Mazume H; Nagataki S
J Gastroenterol Hepatol; 1996 Oct; 11(10):944-8. PubMed ID: 8912132
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus, alcoholic cirrhosis, and hepatocellular carcinoma.
Goeser T; Müller HM; Solbach C; Toex U; Kommerell B; Theilmann L
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):311-5. PubMed ID: 8061579
[TBL] [Abstract][Full Text] [Related]
18. [Investigation on anti-HCV antibody in Shashi District].
Wu X
Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Dec; 14(6):331-3. PubMed ID: 7512448
[TBL] [Abstract][Full Text] [Related]
19. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
20. [Lichen planus and hepatitis C virus. Apropos of 5 new cases].
Hyrailles V; Peyron N; Blanc P; Mark Y; Meunier L; Meynadier J; Larrey D; Michel H
Gastroenterol Clin Biol; 1995 Oct; 19(10):833-6. PubMed ID: 8566564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
